Androstenedione
Androstenedione, Serum/Plasma
Test
Method
LC-MS/MS
Report Includes
Specimens
Serum; Plasma (Na Heparin); Plasma (Li Heparin); Plasma (EDTA)
Clinical Utility
Androstenedione (4-Androstene-3, 17-dione), a 19 carbon steroid, is produced in the adrenal gland and gonads. It is an immediate precursor to both testosterone and estrone, both of which may be subsequently converted to estradiol. Androstenedione is a weak androgen and its physiologic role is not well defined. Serum androstenedione levels are high in fetus and neonates, decrease during childhood and increase at puberty. In normal pubertal and adult male, the major portion of androstenedione derives from the testis, either directly or from conversion of testosterone, while in pubertal and adult female, androstenedione is essentially produced by the adrenal gland and ovary. Androstenedione may play a role in the development of secondary sexual hair during adrenarche. Adrenal androstenedione production gradually declines with advanced age in both male and female. Ovarian androstenedione production is stimulated by luteinizing hormone and varies with the menstrual cycle and decreases after menopause.
Test Location
Hospital for Sick Children, 555 University Avenue, Toronto ON M5G 1X8
Test Version
20-Feb-2024
Specimen
Specimens
Serum; Plasma (Na Heparin); Plasma (Li Heparin); Plasma (EDTA)
Sample Volume
1 mL
Minimum Volume
0.5 mL
Collection & Handling
Handling Information
Store and send frozen.
Stability
Refrigerated | 2 days |
---|---|
Frozen | 2 months |
Test Version
20-Feb-2024
Performance / Interpretation
Method
LC-MS/MS
Turnaround Time
15 days
Results
Name | Units | Reference Range | Conversion Factor | |
---|---|---|---|---|
Androstenedione | nmol/L |
|
||
Test Location
Hospital for Sick Children, 555 University Avenue, Toronto ON M5G 1X8
Test Version
20-Feb-2024
Interface / Setup
HL7 Interface Codes
Order Code | Result Codes | Units |
---|---|---|
ANDROLC | 39766Androstenedione, blood | nmol/L |
Test Version
20-Feb-2024